Overview

Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population

Status:
Unknown status
Trial end date:
2018-04-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the effectiveness and safety of catheter ablation of frequent symptomatic PVCs in the pediatric population as first-line therapy compared with antiarrhythmic drugs.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation
Treatments:
Metoprolol
Verapamil
Criteria
Inclusion Criteria:

- Symptomatic, frequent, premature ventricular complexes (more than 10,000 according to
the 24 hour Holter ECG)

Exclusion Criteria:

- Antiarrhythmic therapy before inclusion Structural heart pathology requiring surgical
correction; Premature ventricular complexes associated with structural heart disease;
Previously performed radiofrequency ablation due to premature ventricular complexes.